Apple has awarded $10 million from its Advanced Manufacturing Fund to COPAN Diagnostics, a company focused on producing sample collection kits for testing COVID-19 to hospitals in the U.S.
The $10 million award also includes Apple employing its sourcing resources to find equipment and materials for COPAN Diagnostics, including new advanced equipment the iPhone-maker is helping design itself.
Apple notes that it will also result in the creation of around 50 new U.S. jobs.
COPAN is a pioneer in the diagnostics world, having previously invented flocked swabs in 2003, and it currently offers the world’s leading transport medium for virus-containing clinical specimens.
This deployment of the Advanced Manufacturing Fund is yet another example of how the company can address the pandemic in a variety of ways that are unique to its global position, expertise and relationships.
No Comments
Leave a comment Cancel